3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
2
Status
Terminated
1
Completed
1
Sponsor Class
OTHER
32
INDUSTRY
17
NIH
16
NETWORK
2
FED
1
Study Type
Interventional
2
Sponsor
Cancer Type
Breast
2
Conditions
Neoplasms
1
Neoplasm Metastasis
1
HER2 Positive Breast Cancer
1
Breast Neoplasms
1
Interventions
Radiotherapy
299
Cisplatin
263
Cyclophosphamide
229
Doxorubicin
176
Paclitaxel
166
Vincristine
160
Carboplatin
149
Filgrastim
139
Etoposide
139
Gemcitabine
118
Fluorouracil
113
Docetaxel
112
Methotrexate
106
Dexamethasone
106
Cytarabine
106
Prednisone
91
Leucovorin
90
Granulocyte Colony-Stimulating Factor
74
Specimen Handling
65
Magnetic Resonance Spectroscopy
61
Capecitabine
59
Irinotecan
58
Radiation
54
Ifosfamide
51
Oxaliplatin
48
Daunorubicin
48
Temozolomide
47
Radiotherapy, Conformal
47
Platinum
47
Peripheral Blood Stem Cell Transplantation
47
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
NETWORK
×
Interventional
×
copanlisib
×
Clear all
NCT02705859
2026-04-13
Panther
Cancer Trials Ireland
Phase 1
Completed
26 enrolled
NCT04042051
2025-07-22
Panthera
Cancer Trials Ireland
Phase 1
Terminated
2 enrolled